Specificity | Clone | Host Species | Reactive Species | Format | Size | Reviews | Supplier | |
---|---|---|---|---|---|---|---|---|
SARS-CoV-2 Spike RBD | 58F8 | Recombinant Human | n/a | unconjugated | 1 mg, 500 ug, 100 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 Spike RBD | 6G7 | Recombinant Human | n/a | unconjugated | 1 mg, 500 ug, 100 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 Spike RBD | monoclonal | Human | mouse | purified | 100 ug, 1 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 Spike RBD | monoclonal | Recombinant Human | n/a | unconjugated | 1 mg, 500 ug, 100 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 Spike RBD | monoclonal | Camelid | n/a | VHH single domain | 2000 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 Spike RBD | monoclonal | Camelid | n/a | VHH single domain | 1000 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 Spike RBD | monoclonal | Camelid | n/a | VHH single domain | 250 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 Spike RBD | monoclonal | Camelid | n/a | VHH single domain | 100 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 Spike RBD | monoclonal | Camelid | n/a | VHH single domain | 50 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 S Protein | OTI3A2 | Mouse | n/a | unconjugated | 100 ul | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 S Protein | OTI3A2 | Mouse | n/a | unconjugated | 100 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 S Protein | OTI3H6 | Mouse | n/a | unconjugated | 100 ul | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 S Protein | OTI3H6 | Mouse | n/a | unconjugated | 100 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 S Protein | OTI4C6 | Mouse | n/a | unconjugated | 100 ul | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 S Protein | OTI4C6 | Mouse | n/a | unconjugated | 100 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV2-S (Rabbit) | polyclonal | Rabbit | n/a | unconjugated | 100 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV2-S (Rat) | polyclonal | Rat | n/a | unconjugated | 100 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV2-S (Rat) | monoclonal | Rat | n/a | unconjugated | 100 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 surface glycoprotein | polyclonal | Rabbit | SARS-CoV-2 | biotin conjugate | n/a | n/a |
ST JOHN'S LABORATORY |
More Info |
SARS-CoV-2 surface glycoprotein | polyclonal | Rabbit | SARS-CoV-2 | fluorescein (FITC) conjugate | n/a | n/a |
ST JOHN'S LABORATORY |
More Info |
SARS-CoV-2 surface glycoprotein | polyclonal | Rabbit | SARS-CoV-2 | affinity purified | n/a | n/a |
ST JOHN'S LABORATORY |
More Info |
S1 SARS-CoV-2 | CBP17469 | Rabbit | n/a | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
ORF3a (SARS-CoV-2) | polyclonal | Goat | SARS-CoV-2 | epitope affinity purified | 300 µg | n/a |
SICGEN ANTIBODIES |
More Info |
ORF3a (SARS-CoV-2) | polyclonal | Goat | SARS-CoV-2 | epitope affinity purified | 300 µg | n/a |
SICGEN ANTIBODIES |
More Info |
ORF7a (SARS-CoV-2) | polyclonal | Goat | SARS-CoV-2 | epitope affinity purified | 300 µg | n/a |
SICGEN ANTIBODIES |
More Info |
ORF7a (SARS-CoV-2) | polyclonal | Goat | SARS-CoV-2 | epitope affinity purified | 300 µg | n/a |
SICGEN ANTIBODIES |
More Info |
SARS-CoV-2(S1)-6 | s309 | Recombinant Human | n/a | unconjugated | 0.1 mg | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 (2019-nCoV) Spike RBD | polyclonal | Rabbit | SARS-CoV-2 | antigen affinity purified | 100µL | n/a |
SINO BIOLOGICAL, INC. |
More Info |
SARS-CoV-2 (2019-nCoV) Spike RBD | polyclonal | Rabbit | SARS-CoV-2 | peroxidase (HRP) conjugate | 100µg | n/a |
SINO BIOLOGICAL, INC. |
More Info |
SARS-CoV-2 Spike RBD Protein | monoclonal | Recombinant Rabbit | SARS-CoV-2 | peroxidase (HRP) conjugate | 100µg | n/a |
SINO BIOLOGICAL, INC. |
More Info |
SARS-CoV-2 Spike S1 | monoclonal | Mouse | SARS-CoV-2 | Protein A purified | 100µL | n/a |
SINO BIOLOGICAL, INC. |
More Info |
SARS-CoV-2 Spike S1 | monoclonal | Mouse | SARS-CoV-2 | biotin conjugate | 100µg | n/a |
SINO BIOLOGICAL, INC. |
More Info |
SARS-CoV-2 Spike S1 | monoclonal | Mouse | SARS-CoV-2 | peroxidase (HRP) conjugate | 100µg | n/a |
SINO BIOLOGICAL, INC. |
More Info |
SARS-CoV-2 (2019-nCoV) Spike protein S2 | polyclonal | Rabbit | n/a | unconjugated | 50 ul, 100 ul, 200 ul | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 (2019-nCoV) Spike protein S2 | polyclonal | Rabbit | n/a | unconjugated | 200 ul, 50 ul, 100 ul | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2(2019-nCoV) RBD Neutralizing | CV30 | Human | n/a | unconjugated | 100 ug, 50 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2(2019-nCoV) RBD Neutralizing | REGN10933 | Human | n/a | unconjugated | 100 ug, 50 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2(2019-nCoV) RBD Neutralizing | REGN10987 | Human | n/a | unconjugated | 100 ug, 50 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2(2019-nCoV) S-NTD | E1 | Mouse | n/a | VHH single domain | 100 ug, 50 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV S RBD | monoclonal | Recombinant Camelid | SARS-CoV, WIV1-CoV and SARS-CoV-2 | single domain | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV S RBD | monoclonal | Recombinant Human | SARS-CoV, WIV1-CoV and SARS-CoV-2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV S RBD | monoclonal | Recombinant Human | SARS-CoV, WIV1-CoV and SARS-CoV-2 | unconjugated | n/a | n/a |
CREATIVE BIOLABS, INC. |
More Info |
SARS-CoV-2(2019-nCoV) RBD Neutralizing | CB6, JS016 | Human | n/a | unconjugated | 100 ug, 50 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2(2019-nCoV) RBD Neutralizing | EY6A | Human | n/a | unconjugated | 50 ug, 100 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2(2019-nCoV) S-NTD | 4A8 | Human | n/a | unconjugated | 100 ug, 50 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 S Protein RBD | A20100I | Mouse | SARS-CoV-2 | purified, low endotoxin, azide-free | 100 µg | n/a |
BIOLEGEND |
More Info |
SARS-CoV-2 S Protein RBD | A20100I | Mouse | SARS-CoV-2 | purified, low endotoxin, azide-free | 1 mg | n/a |
BIOLEGEND |
More Info |
SARS-CoV-2(2019-nCoV) RBD Neutralizing | VHH72 | Mouse | n/a | VHH single domain | 100 ug, 50 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 Spike protein (RBD of S1 subunit) | CR3022 | n/a | n/a | purified | 100 ug | n/a |
BIORBYT LTD. |
More Info |
SARS-CoV-2 RBD Potent Neutralizing | AM128 | Chimeric | n/a | purified | 100ug | n/a |
ACROBIOSYSTEMS USA |
More Info |
SARS-CoV-2 RBD Potent Neutralizing | AM128 | Chimeric | n/a | purified | 1mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
SARS-CoV-2 RBD Potent Neutralizing | AM180 | Recombinant Human | n/a | purified | 100ug | n/a |
ACROBIOSYSTEMS USA |
More Info |
SARS-CoV-2 RBD Potent Neutralizing | AM180 | Recombinant Human | n/a | purified | 1mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
SARS-CoV-2 Spike RBD Broadly | 2G7F5 | Mouse | n/a | purified | 100ug | n/a |
ACROBIOSYSTEMS USA |
More Info |
SARS-CoV-2 Spike RBD Broadly | 2G7F5 | Mouse | n/a | purified | 1mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
SARS-CoV-2 Spike RBD Neutralizing | AM122 | Chimeric | n/a | biotin conjugate | 25ug | n/a |
ACROBIOSYSTEMS USA |
More Info |
SARS-CoV-2 Spike RBD Neutralizing | AM122 | Chimeric | n/a | biotin conjugate | 200ug | n/a |
ACROBIOSYSTEMS USA |
More Info |
SARS-CoV-2 Spike RBD Neutralizing | AM122 | Chimeric | n/a | phycoerythrin (PE) conjugate | 25 tests | n/a |
ACROBIOSYSTEMS USA |
More Info |
SARS-CoV-2 Spike RBD Neutralizing | AM122 | Chimeric | n/a | phycoerythrin (PE) conjugate | 200 tests | n/a |
ACROBIOSYSTEMS USA |
More Info |
SARS-CoV-2 Spike RBD Neutralizing | AM122 | Chimeric | n/a | purified | 1mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
SARS-CoV-2 Spike RBD Neutralizing | AM122 | Chimeric | n/a | purified | 100ug | n/a |
ACROBIOSYSTEMS USA |
More Info |
SARS-CoV-2 Spike RBD Neutralizing | AM122 | Chimeric | n/a | purified | 100ug | n/a |
ACROBIOSYSTEMS USA |
More Info |
SARS-CoV-2 Spike RBD Neutralizing | AM122 | Chimeric | n/a | purified | 1mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
SARS-CoV-2 Spike RBD Neutralizing | AM122 | Chimeric | n/a | purified | 100ug | n/a |
ACROBIOSYSTEMS USA |
More Info |
SARS-CoV-2 Spike RBD Neutralizing | AM122 | Chimeric | n/a | purified | 1mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
SARS-CoV-2 Spike RBD Neutralizing | AM122 | Chimeric | n/a | purified | 100ug | n/a |
ACROBIOSYSTEMS USA |
More Info |
SARS-CoV-2 Spike RBD Neutralizing | AM122 | Chimeric | n/a | purified | 1mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
SARS-CoV-2 Spike RBD Neutralizing | AM122 | Chimeric | n/a | purified | 10mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
SARS-CoV-2 Spike RBD Neutralizing | AM122 | Chimeric | n/a | purified | 100mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
SARS-CoV-2 Spike RBD Neutralizing | AM122 | Chimeric | n/a | purified | 100ug | n/a |
ACROBIOSYSTEMS USA |
More Info |
SARS-CoV-2 Spike RBD Neutralizing | AM122 | Chimeric | n/a | purified | 1mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
SARS-CoV-2 Spike RBD Neutralizing | AM122 | Mouse | n/a | purified | 100ug | n/a |
ACROBIOSYSTEMS USA |
More Info |
SARS-CoV-2 Spike RBD Neutralizing | AM122 | Mouse | n/a | purified | 1mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
SARS-CoV-2 Spike RBD Neutralizing | AS35 | Recombinant Human | n/a | purified | 100ug | n/a |
ACROBIOSYSTEMS USA |
More Info |
SARS-CoV-2 Spike RBD Neutralizing | AS35 | Recombinant Human | n/a | purified | 1mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
SARS-CoV-2 Spike S1 | AS58 | Mouse | n/a | purified | 100ug | n/a |
ACROBIOSYSTEMS USA |
More Info |
SARS-CoV-2 Spike S1 | AS58 | Mouse | n/a | purified | 1mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
SARS-CoV-2 Spike S1 | AS58 | Mouse | n/a | purified | 100ug | n/a |
ACROBIOSYSTEMS USA |
More Info |
SARS-CoV-2 Spike S1 | AS58 | Mouse | n/a | purified | 1mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
SARS-CoV-2 Spike S1 | AS59 | Mouse | n/a | purified | 100ug | n/a |
ACROBIOSYSTEMS USA |
More Info |
SARS-CoV-2 Spike S1 | AS59 | Mouse | n/a | purified | 1mg | n/a |
ACROBIOSYSTEMS USA |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Mouse | SARS-CoV-2, SARS-Cov | F(ab)2 fragment-His-tagged | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Human | SARS-CoV-2, SARS-Cov | F(ab)2 fragment-His-tagged | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Mouse | SARS-CoV-2, SARS-Cov | Fab fragment-His-tagged | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Human | SARS-CoV-2, SARS-Cov | Fab fragment-His-tagged | 100 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Ferret | SARS-CoV-2, SARS-Cov | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Human | SARS-CoV-2, SARS-Cov | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Human | SARS-CoV-2, SARS-Cov | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Rabbit | SARS-CoV-2, SARS-Cov | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Mouse | SARS-CoV-2, SARS-Cov | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Human | SARS-CoV-2, SARS-Cov | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Human | SARS-CoV-2, SARS-Cov | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Ferret | SARS-CoV-2, SARS-Cov | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Cat | SARS-CoV-2, SARS-Cov | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Human | SARS-CoV-2, SARS-Cov | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Mouse | SARS-CoV-2, SARS-Cov | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Mouse | SARS-CoV-2, SARS-Cov | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Human | SARS-CoV-2, SARS-Cov | purified | 200 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Human | SARS-CoV-2, SARS-Cov | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |
SARS-CoV-2 and SARS-CoV nucleocapsid | mBG17 | Recombinant Mouse | SARS-CoV-2, SARS-Cov | purified | 50 µg | n/a |
ABSOLUTE ANTIBODY LTD. |
More Info |